Read more from the original source: Novartis reports positive topline results from second Phase III trial of Beovu® in patients with diabetic macular edema
Read more from the original source: Novartis reports positive topline results from second Phase III trial of Beovu® in patients with diabetic macular edema
More here: Roche launches cobas PIK3CA Mutation Test for patients with advanced or metastatic breast cancer in countries accepting the CE mark
Original post: Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030
Read the original post: Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
See the article here: Nicox Initiates Phase 2b Trial of NCX 4251, a Potential First-in-Class Treatment for Blepharitis
Read more: BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
Continued here: Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™
See the rest here: Financial calendar for Zealand Pharma in 2021
Read this article: Cynata Secures $15m Placement Led By $10m from Healthcare Investor BioScience Managers to Expand Development Pipeline
Link: ExCellThera receives Priority Medicines (PRIME) designation from European Medicines Agency for ECT-001 Cell Therapy
Recent Comments